Establishment of a Predictive Model for Immunotherapy Response in Pancreatic Cancer

This project aims to establish a single-center, prospective, observational clinical cohort for pancreatic cancer immunotherapy. It plans to enroll 100 patients with advanced pancreatic cancer, collecting tumor tissue sections, plasma, serum, and fecal samples. Through multi-omics analysis including proteomics, metabolomics, and microbiomics, the project will develop predictive models for immunotherapy response.

NCT Number	NCT07271823
Lead Sponsor	Zhejiang Cancer Hospital
Conditions	Pancreatic Cancer Non-resectable
Enrollment	100 participants
Start Date	2024-09-01
Primary Completion	2026-12-31 (estimated)
Study Completion	2026-12-31 (estimated)
Updated on ClinicalTrials.gov	2025-12-09